# Aquabounty Technologies Inc: overview AQB · Nasdaq · CIK 1603978 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aqb.md) · [Financials](/companies/aqb/financials.md) · [Filings](/companies/aqb/filings.md) · [Insiders](/companies/aqb/insiders.md) Latest reported revenue: [$47.8k](/filings/0001603978-24-000072.md) for Q3 FY2024, three months to 2024-09-30, from the 10-Q filed Nov 5, 2024 (XBRL us-gaap:Revenues, accession 0001603978-24-000072). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [47.8](/filings/0001603978-24-000072.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(3380.5%)](/filings/0001603978-25-000069.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(7120.2%)](/filings/0001603978-25-000069.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.88)](/filings/0001603978-25-000069.md) | not reported | [0.11](/filings/0001603978-26-000066.md) | [(0.87)](/filings/0001603978-26-000084.md) | [(0.36)](/filings/0001603978-25-000069.md) | not reported | [(0.26)](/filings/0001603978-26-000066.md) | [(0.32)](/filings/0001603978-26-000084.md) | | Free cash flow | $k | [(4,681) d](/filings/0001603978-25-000069.md) | [(1,371) d](/filings/0001603978-26-000029.md) | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1.2](/filings/0001603978-23-000007.md) | [3.1](/filings/0001603978-24-000013.md) | [2.5](/filings/0001603978-24-000013.md) | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(1883.0%)](/filings/0001603978-23-000007.md) | [(711.6%)](/filings/0001603978-24-000013.md) | [(552.9%)](/filings/0001603978-25-000014.md) | not reported | not reported | | Net margin | % | [(1900.1%)](/filings/0001603978-23-000007.md) | [(706.3%)](/filings/0001603978-24-000013.md) | [(1114.5%)](/filings/0001603978-25-000014.md) | not reported | not reported | | Diluted EPS | $ per share | [(0.32)](/filings/0001603978-23-000007.md) | [(5.78)](/filings/0001603978-24-000013.md) | [(7.17)](/filings/0001603978-25-000014.md) | [(38.65)](/filings/0001603978-26-000029.md) | [(4.77)](/filings/0001603978-26-000029.md) | | Free cash flow | $m | [(26.2)](/filings/0001603978-23-000007.md) | [(88.5)](/filings/0001603978-24-000013.md) | [(93.1)](/filings/0001603978-25-000014.md) | [(16.8)](/filings/0001603978-26-000029.md) | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aqb/insiders.md) | Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing | | --- | --- | --- | --- | ---: | ---: | ---: | --- | | 2018-01-17 | [Kirk Randal J](/insiders/1091823.md) | 10% owner | Purchase (P) | 1,538,461 | $3.25 | $5.0m | [Form 4](/filings/0001140361-18-002633.md) | | 2017-01-18 | [Kirk Randal J](/insiders/1091823.md) | 10% owner | Purchase (P) | 2,421,073 | $10.33 | $25.0m | [Form 4](/filings/0001140361-17-002429.md) | ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $147.8k | 138,163 | | Added +23,916 | | [EPIQ PARTNERS, LLC](/funds/1799435.md) | 2026-06-30 | $95.2k | 89,000 | | Unchanged | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $88.6k | 82,803 | | Reduced −9,998 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $50.9k | 47,528 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $43.4k | 40,567 | | Reduced −15,394 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $34.1k | 31,880 | | Reduced −2,148 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $25.0k | 23,371 | | Unchanged | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $13.3k | 12,443 | | Added +535 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $11.4k | 10,649 | | Unchanged | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $4.5k | 4,177 | | Added +88 | ## Recent filings [All 464 filings](/companies/aqb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 16:03 ET | [8-K](/filings/0001603978-26-000104.md) | 8.01 Other events | 0001603978-26-000104 | | 2026-10-08 | 08:04 ET | [8-K](/filings/0001603978-26-000092.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001603978-26-000092 | | 2026-08-06 | 08:34 ET | [8-K](/filings/0001603978-26-000086.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001603978-26-000086 | | 2026-08-06 | 08:02 ET | [10-Q](/filings/0001603978-26-000084.md) | Quarterly report, period 2026-06-30 | 0001603978-26-000084 | | 2026-07-08 | 08:04 ET | [8-K](/filings/0001603978-26-000077.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001603978-26-000077 | | 2026-06-30 | 16:13 ET | [8-K](/filings/0001603978-26-000073.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001603978-26-000073 | | 2026-06-25 | 08:13 ET | [8-K](/filings/0001603978-26-000070.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001603978-26-000070 | | 2026-05-07 | 08:26 ET | [10-Q](/filings/0001603978-26-000066.md) | Quarterly report, period 2026-03-31 | 0001603978-26-000066 | | 2026-05-01 | 08:01 ET | [DEF 14A](/filings/0001603978-26-000056.md) | Proxy statement, period 2026-05-01 | 0001603978-26-000056 | | 2026-04-17 | 08:04 ET | [8-K/A](/filings/0001603978-26-000049.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001603978-26-000049 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001603978-26-000029.md), filed Mar 31, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1603978 - Tickers: AQB - Exchange: Nasdaq - SIC code: 900 Fishing, Hunting and Trapping - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 06:02 ET. No prices; not investment advice.